Skip to content
10-K

Annual Report

MAGELLAN HEALTH INC

0001558370-21-002031

← back to feed
Filed
Feb 26, 2021 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2020 · Feb 19, 2021 25.97M sh
Shares Diluted FY 2020 · Dec 31, 2020 25.78M sh
Shares Diluted FY 2020 · Dec 31, 2020 25.53M sh
Shares Diluted FY 2020 · Sep 30, 2020 25.45M sh
Shares Diluted FY 2020 · Jun 30, 2020 25.28M sh
Shares Diluted FY 2020 · Mar 31, 2020 24.87M sh
Shares Diluted FY 2020 · Dec 31, 2019 24.91M sh
Shares Diluted FY 2020 · Dec 31, 2019 24.56M sh
Shares Diluted FY 2020 · Sep 30, 2019 24.71M sh
Shares Diluted FY 2020 · Jun 30, 2019 24.42M sh
Shares Diluted FY 2020 · Mar 31, 2019 24.21M sh
Shares Diluted FY 2020 · Dec 31, 2018 25.04M sh
Capex FY 2020 · Dec 31, 2020 $75.48M
Capex FY 2020 · Dec 31, 2019 $60.4M
Capex FY 2020 · Dec 31, 2018 $68.28M
Operating Cash Flow FY 2020 · Dec 31, 2020 $450.76M
Operating Cash Flow FY 2020 · Dec 31, 2019 $115.85M
Operating Cash Flow FY 2020 · Dec 31, 2018 $164.84M
Stockholders Equity FY 2020 · Dec 31, 2020 $1.87B
Stockholders Equity FY 2020 · Dec 31, 2019 $1.4B
Stockholders Equity FY 2020 · Dec 31, 2018 $1.29B
Stockholders Equity FY 2020 · Dec 31, 2017 $1.28B
Current Liabilities FY 2020 · Dec 31, 2020 $737.58M
Current Liabilities FY 2020 · Dec 31, 2019 $910.15M
Total Liabilities FY 2020 · Dec 31, 2020 $1.46B
Total Liabilities FY 2020 · Dec 31, 2019 $1.69B
Current Assets FY 2020 · Dec 31, 2020 $2.16B
Current Assets FY 2020 · Dec 31, 2019 $1.67B
Total Assets FY 2020 · Dec 31, 2020 $3.36B
Total Assets FY 2020 · Dec 31, 2019 $3.09B
Eps Diluted FY 2020 · Dec 31, 2020 $10.43
Eps Diluted FY 2020 · Dec 31, 2020 $14.98
Eps Diluted FY 2020 · Sep 30, 2020 $0.46
Eps Diluted FY 2020 · Jun 30, 2020 $3.30
Eps Diluted FY 2020 · Mar 31, 2020 $0.74
Eps Diluted FY 2020 · Dec 31, 2019 $0.83
Eps Diluted restated FY 2020 · Dec 31, 2019 $2.27
Eps Diluted FY 2020 · Sep 30, 2019 $0.86
Eps Diluted FY 2020 · Jun 30, 2019 $0.56
Eps Diluted FY 2020 · Mar 31, 2019 $0.02
Eps Diluted FY 2020 · Dec 31, 2018 $0.97
Eps Basic FY 2020 · Dec 31, 2020 $10.43
Eps Basic FY 2020 · Dec 31, 2020 $15.14
Eps Basic FY 2020 · Sep 30, 2020 $0.46
Eps Basic FY 2020 · Jun 30, 2020 $3.33
Eps Basic FY 2020 · Mar 31, 2020 $0.74
Eps Basic FY 2020 · Dec 31, 2019 $0.84
Eps Basic FY 2020 · Dec 31, 2019 $2.31
Eps Basic FY 2020 · Sep 30, 2019 $0.87
Eps Basic FY 2020 · Jun 30, 2019 $0.56
Eps Basic FY 2020 · Mar 31, 2019 $0.02
Eps Basic FY 2020 · Dec 31, 2018 $0.99
Net Income FY 2020 · Dec 31, 2020 $268.93M
Net Income FY 2020 · Dec 31, 2020 $382.34M
Net Income FY 2020 · Sep 30, 2020 $11.65M
Net Income FY 2020 · Jun 30, 2020 $83.51M
Net Income FY 2020 · Mar 31, 2020 $18.25M
Net Income FY 2020 · Dec 31, 2019 $20.58M
Net Income FY 2020 · Dec 31, 2019 $55.9M
Net Income FY 2020 · Sep 30, 2019 $21.27M
Net Income FY 2020 · Jun 30, 2019 $13.61M
Net Income FY 2020 · Mar 31, 2019 $431K
Net Income FY 2020 · Dec 31, 2018 $24.18M
Gross Profit FY 2020 · Dec 31, 2020 $143.96M
Gross Profit restated FY 2020 · Dec 31, 2019 $185.81M
Gross Profit restated FY 2020 · Dec 31, 2018 $206.26M
Cost Of Revenue FY 2020 · Dec 31, 2020 $559.14M
Cost Of Revenue FY 2020 · Dec 31, 2020 $2.18B
Cost Of Revenue FY 2020 · Sep 30, 2020 $560.27M
Cost Of Revenue FY 2020 · Jun 30, 2020 $528.07M
Cost Of Revenue FY 2020 · Mar 31, 2020 $533.24M
Cost Of Revenue restated FY 2020 · Dec 31, 2019 $507.92M
Cost Of Revenue restated FY 2020 · Dec 31, 2019 $2.06B
Cost Of Revenue restated FY 2020 · Sep 30, 2019 $523.97M
Cost Of Revenue restated FY 2020 · Jun 30, 2019 $501.08M
Cost Of Revenue restated FY 2020 · Mar 31, 2019 $526.31M
Cost Of Revenue restated FY 2020 · Dec 31, 2018 $2.45B
Stock Repurchased FY 2020 · Dec 31, 2019 $4.13M
Stock Repurchased FY 2020 · Dec 31, 2018 $62.64M